Md Anderson Cancer Centre Madrid

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma1 trial
• Mantle cell lymphoma1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Incyte Corporation2 trials

Closed trials

• Completed

  A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

  NCT03126019· Phase 2· Incyte Corporation· Source

• Completed

  A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

  NCT03235544· Phase 2· Incyte Corporation· Source